ReachMD

Are you up to date on the key clinical data for available immuno-oncologic agents in advanced endometrial and cervical cancers?

This educational series examines the significance and potential impact of immunotherapy and antibody-drug conjugates in patients with advanced endometrial and cervical cancers. Our global experts discuss key clinical data from first- and second-line treatment, management considerations during immuno-oncologic therapy, and more!

Provided by:

In Partnership with: